Forum allows healthcare professionals to consider probiotics for patient wellbeing

GPs who have a chance to evaluate the current evidence on probiotics and hear from experts firsthand on their relevance to clinical practice are much more likely to consider them, according to the findings of an interactive debate at the RCGPs Annual Primary Care Conference in Harrogate this week.

In a panel discussion titled "Probiotics: science or hocus pocus?", sponsored by Danone and chaired by the BBC's John Humphrys, participants heard representations on the clinical evidence and practical experience from leading gastroenterologist Professor Peter Whorwell and nutritionist Professor Ian Rowland. The panellists then sought to understand how this evidence was currently being interpreted in primary care.

Commenting on the debate, panellist Professor Roger Jones, Emeritus Professor of General Practice, at King's College said: "It's really valuable to have the opportunity to hear the evidence on probiotics from experts in this field. We all see many patients who are experiencing IBS or digestive discomfort, like bloating or distension. When the evidence supports using probiotics to help patients manage these conditions for themselves, we should be thinking about recommending them."

Panellist Professor Ian Rowland, Professor of Human Nutrition at the University of Reading, added: "I am often asked about the evidence behind probiotics. I was glad to have the opportunity to talk to primary care practitioners about my experiences as I do believe probiotics could be of benefit to many patients on a daily basis."

Using interactive key pads throughout the debate, the audience was asked to consider evidence on probiotics around four key areas - general evidence, digestive health, antibiotic-associated diarrhoea and the likelihood of participants endorsing a patient's decision to choose probiotics. The results of the interactive session showed:

Prior to the expert discussion:

  • Some 35% of GPs would recommend probiotics to alleviate digestive discomfort
  • Some 63% of GPs are unaware of the evidence on probiotics with antibiotic-associated diarrhoea
  • Some 78% of GPs would definitely support a patient's decision to use probiotics
  • 85% of GPs are more likely to consider the role of probiotics in health and well being post the discussion forum.

"Danone is dedicated to providing health through food. We are very confident in the evidence behind our probiotic yogurts, as demonstrated by the wealth of clinical data," said Connie Hersch, Director of Health Affairs at Danone. "This forum really allowed us to bring that evidence closer to healthcare professionals so they can consider how probiotics may improve patient wellbeing."

Comments

  1. smilinggreenmom smilinggreenmom United States says:

    Thank goodness that more Docs are becoming aware and ready to help their patients with probiotics! I know first hand that probiotics are amazing because there was not one doctor, medication or cream that could help our little boy with his severe eczema and food intolerances until we gave him chewable probiotics. Once he started this he became like a totally different child! He is so much better now and we are so thankful!! I hope more docs will help their patients with these!

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enhancing the adoption of pragmatic clinical trial results in healthcare systems